Target intelligence / Profile preview

Endolymph

Molecular classification
Other, Extracellular fluid
01

Overview

Endolymph is the specialized extracellular fluid contained within the membranous labyrinth of the inner ear, specifically the cochlear duct and the vestibular organs [1][3]. It is unique among extracellular fluids due to its high potassium (K+) and low sodium (Na+) concentration, a composition maintained by the stria vascularis that is essential for generating the endocochlear potential required for hair cell depolarization [1]. While endolymph is a physiological fluid compartment rather than a specific molecular target like a receptor or enzyme, its regulation is central to auditory and vestibular health [2]. Pathological expansion of the endolymphatic space, known as endolymphatic hydrops, is the primary histological finding in Meniere's disease, leading to episodic vertigo, tinnitus, and progressive hearing loss [2][4]. Pharmacological management typically involves the use of diuretics and osmotic agents to reduce endolymphatic pressure and volume, thereby alleviating clinical symptoms [2][4]. (Sources: [1] StatPearls: Physiology, Inner Ear; [2] StatPearls: Meniere Disease; [3] Britannica: Endolymph; [4] MSD Manual: Meniere Disease)

Other names
Scarpa's fluidEndolymphatic fluid
02

Mechanism of action

Reduction of endolymphatic volume and pressure via osmotic dehydration or inhibition of carbonic anhydrase-mediated fluid production; modulation of microvascular circulation to the stria vascularis.

03

Biological functions

Auditory transductionVestibular functionIonic homeostasisMaintenance of endocochlear potential
04

Disease associations

Meniere's diseaseEndolymphatic hydropsSensorineural hearing lossVertigoTinnitus
05

Safety considerations

Electrolyte imbalance (hypokalemia)Systemic dehydrationOtotoxicity from intratympanic drug administrationRenal impairment
06

Interacting drugs

Acetazolamide

5 more in the full profile.

07

Biomarkers

Electrocochleography (ECochG) summating potential to action potential (SP/AP) ratioVestibular evoked myogenic potentials (VEMP)Magnetic resonance imaging (MRI) with gadolinium enhancement

Beyond the preview

Go deeper on Endolymph.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endolymph.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call